Wells Fargo Maintains Underweight on Molina Healthcare, Lowers Price Target to $282
Wells Fargo analyst Stephen Baxter maintains Molina Healthcare (NYSE:MOH) with a Underweight and lowers the price target from $307 to $282.
Wells Fargo Maintains Underweight on Molina Healthcare, Lowers Price Target to $307
Wells Fargo analyst Stephen Baxter maintains Molina Healthcare (NYSE:MOH) with a Underweight and lowers the price target from $340 to $307.
A Bearish Sign Appears On Molina Healthcare’s Chart
If history is any guide, there may be trouble ahead for shares of Molina Healthcare (NYSE:MOH). A so-called…
Barclays Maintains Overweight on Molina Healthcare, Lowers Price Target to $375
Barclays analyst Steve Valiquette maintains Molina Healthcare (NYSE:MOH) with a Overweight and lowers the price target from $400 to $375.
Wells Fargo Maintains Underweight on Molina Healthcare, Lowers Price Target to $340
Wells Fargo analyst Stephen Baxter maintains Molina Healthcare (NYSE:MOH) with a Underweight and lowers the price target from $345 to $340.
Molina Healthcare Projects Its California Medicaid Membership Will Double Under Revised Medi-Cal Contract Awards; Expects Annual Premium Revenue Related To Medi-Cal Contract Of ~$3.9B For FY24
Molina Healthcare, Inc. (NYSE:MOH) ("Molina") confirmed today that the California Department of Health Care Services ("DHCS") has announced the awards of Medi-Cal contracts to Molina Healthcare of
Benzinga’s Top Ratings Upgrades, Downgrades For December 13, 2022
Upgrades For Equinix Inc (NASDAQ:EQIX), Cowen & Co. upgraded the previous rating of Market Perform to Outperform. In…
B of A Securities Upgrades Molina Healthcare to Neutral, Announces $388 Price Target
B of A Securities analyst Kevin Fischbeck upgrades Molina Healthcare (NYSE:MOH) from Underperform to Neutral and announces $388 price target.
Deutsche Bank Maintains Hold on Molina Healthcare, Raises Price Target to $355
Deutsche Bank analyst George Hill maintains Molina Healthcare (NYSE:MOH) with a Hold and raises the price target from $315 to $355.
Barclays Maintains Overweight on Molina Healthcare, Raises Price Target to $400
Barclays analyst Steven Valiquette maintains Molina Healthcare (NYSE:MOH) with a Overweight and raises the price target from $380 to $400.